AbbVie (ABBV) to invest USD 380mln in north Chicago to further expand active pharmaceutical ingredient manufacturing in the US; construction to begin in spring 2026, operational by 2029
Importance
Level 1
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#ABBVIE INC#ABBV.US#FOREX#EQUITIES#METALS#EU SESSION#US SESSION#BIOTECHNOLOGY#METALS & MINING#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ABBVIE INC#ABBV#DXY#US EQUITIES